Cargando…
Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
NF-κB-inducing kinase (NIK), the essential upstream kinase, which regulates activation of the noncanonical NF-κB pathway, has important roles in regulating immunity and inflammation. In addition, NIK is vital for maintaining cellular health through its control of fundamental cellular processes, incl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696043/ https://www.ncbi.nlm.nih.gov/pubmed/33187137 http://dx.doi.org/10.3390/ijms21228470 |
_version_ | 1783615318261760000 |
---|---|
author | Pflug, Kathryn M. Sitcheran, Raquel |
author_facet | Pflug, Kathryn M. Sitcheran, Raquel |
author_sort | Pflug, Kathryn M. |
collection | PubMed |
description | NF-κB-inducing kinase (NIK), the essential upstream kinase, which regulates activation of the noncanonical NF-κB pathway, has important roles in regulating immunity and inflammation. In addition, NIK is vital for maintaining cellular health through its control of fundamental cellular processes, including differentiation, growth, and cell survival. As such aberrant expression or regulation of NIK is associated with several disease states. For example, loss of NIK leads to severe immune defects, while the overexpression of NIK is observed in inflammatory diseases, metabolic disorders, and the development and progression of cancer. This review discusses recent studies investigating the therapeutic potential of NIK inhibitors in various diseases. |
format | Online Article Text |
id | pubmed-7696043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76960432020-11-29 Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer Pflug, Kathryn M. Sitcheran, Raquel Int J Mol Sci Review NF-κB-inducing kinase (NIK), the essential upstream kinase, which regulates activation of the noncanonical NF-κB pathway, has important roles in regulating immunity and inflammation. In addition, NIK is vital for maintaining cellular health through its control of fundamental cellular processes, including differentiation, growth, and cell survival. As such aberrant expression or regulation of NIK is associated with several disease states. For example, loss of NIK leads to severe immune defects, while the overexpression of NIK is observed in inflammatory diseases, metabolic disorders, and the development and progression of cancer. This review discusses recent studies investigating the therapeutic potential of NIK inhibitors in various diseases. MDPI 2020-11-11 /pmc/articles/PMC7696043/ /pubmed/33187137 http://dx.doi.org/10.3390/ijms21228470 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pflug, Kathryn M. Sitcheran, Raquel Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer |
title | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer |
title_full | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer |
title_fullStr | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer |
title_full_unstemmed | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer |
title_short | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer |
title_sort | targeting nf-κb-inducing kinase (nik) in immunity, inflammation, and cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696043/ https://www.ncbi.nlm.nih.gov/pubmed/33187137 http://dx.doi.org/10.3390/ijms21228470 |
work_keys_str_mv | AT pflugkathrynm targetingnfkbinducingkinasenikinimmunityinflammationandcancer AT sitcheranraquel targetingnfkbinducingkinasenikinimmunityinflammationandcancer |